• 2017 second quarter net revenues up 18 percent to $16.1 million
• PayOnline, a flexible e-commerce payment solutions platform, launches in U.S.
• Net Element is strategically poised for growth in the U.S. and emerging countries

Mobile-based purchasing by the world’s consumers is booming thanks to smartphones and other portable devices. Net Element (NASDAQ: NETE) is tapping into that expanding e-commerce world with its focus on small- to medium-sized businesses in the United States and select emerging markets.

Florida-based Net Element is a global financial technology company delivering a wide range of value-added solutions that support electronic payments in an omni-channel environment that spans point-of-sale, e-commerce, and mobile devices.

Its PayOnline subsidiary, launched July 2017 in the United States, supports more than 100 payment methods in as many currencies, in addition to credit card acceptance, and it is certified with most payment processors in the United States and globally.

PayOnline’s Instant Payment Module utilizes chat-bots with four popular instant messaging apps to help retailers interact with consumers, which Net Element believes represents a global opportunity for the company.

This major consumer habit of buying online, fueled by millennials, bodes well for Net Element and its long-term growth opportunities as e-commerce markets expand.

An online retail forecast from Forrester, cited by Digital Commerce 360, predicts that U.S. shoppers will splurge on nearly $460 billion in online sales in 2017, proving the global marketplace is ripe for Net Element’s ideas (http://dtn.fm/w4DoU).

“We are pleased with our continued growth. Our results are a reflection of our ability to deliver growth,” Oleg Firer, CEO of Net Element, said prior to the company’s August 15 conference call to discuss second quarter 2017 financial results and business highlights. “We are excited about our strategic initiatives for the remainder of the year as we continue to streamline international operations and reduce operating expenses while managing the strong U.S. growth and expansion.”

For more information, visit the company’s website at www.NetElement.com

• Training programs already offered in 22 states
• Upending traditional approach to delivering education and training
• Employing VR technology to cut costs and improve accessibility

Taking Francis Bacon’s aphorism ‘if the mountain will not go to Mohammed, then Mohammed must go to the mountain’ to heart, ProBility Media Corp. (OTCQB: PBYA) plans to deliver its extensive suite of technical training programs nationwide through virtual reality and a host of other cutting edge technologies. At present, the company offers programs in 22 states, so it is already halfway to realizing its ambitious goal. Partnering with developers of three-dimensional (3D) technology, ProBility will create virtual reality and interactive media content designed specifically for education and training purposes. The innovative edtech company wants nothing less than to create the first full service training and career advancement brand for technical vocations and trades.

Recent innovations in information technology have expanded the bounds of countless industries, and the field of education is no different. Historically, delivering educational services meant the construction of costly infrastructure such as schools, colleges, and laboratories, as well as funding emoluments for teachers and instructors. In addition, this model placed the provision of services in one fixed location. Like a mountain, a college or training facility cannot move, which means that not only Mohammed but students must oftentimes travel for long distances, perhaps relocate, if they wish to attend a particular school.

This traditional approach affects the market for education from both the demand and the supply ends. Supply quantity is curtailed, since building schools and community colleges is expensive. Likewise, demand quantity is dampened because of high tuition costs and the inevitable barriers to availability and accessibility, both adverse outcomes resulting because schools can’t go to students. That’s why ProBility’s approach, which takes schooling to students, is such a big deal, killing, as it does, two birds with one stone. With ProBility’s eLearning VR educational programs, a student can sit in the comfort of his or her home and enjoy all the benefits of a classroom or lab environment.

The potential for a nationwide expansion of ProBility’s eLearning programs is promising. The market for employer-based formal training is estimated at around $177 billion annually. Most of that (52%) is in service industries, with manufacturing accounting for 14%; transportation and utilities another 11%; finance, insurance and real estate 9%; and retail 9%. Construction and mining together account for 4% of total spending on employer-based formal training.

A recent New York Times piece (http://dtn.fm/d4G3b) detailed how West Virginia ‘is now leading the way in turning vocational education from a Plan B for underachieving students into what policy makers hope will be a fuel source for the state’s economic revival. Simulated workplaces, overseen by teachers newly trained in important state industries like health, coal and even fracking, are now operating in schools across the state. Students punch a time clock, are assigned professional roles like foreman or safety supervisor, and are even offered several vacation days of their choice in addition to regular school breaks.’

VR technology is currently employed to deliver ProBility’s crane training programs. ProBility has collaborated with GlobalSim, a VR Crane industry leader, to offer a cutting-edge VR simulation platform that combines a comprehensive training program with superb realism, all at an affordable price. The GlobalSim VR simulator comes equipped with a headset that offers an unlimited field-of-view in a mixed reality setting, allowing for a completely immersive experience. Just as with traditional simulator systems, the GlobalSim VR platform uses real equipment controls, joysticks and buttons, so operators can become familiar with the actual equipment they will use in the workplace.

As part of its strategy to offer training programs in crane operation, ProBility also signed an exclusive publishing and distribution deal with All Purpose Crane Training (AP), which provides nationwide crane-rigging training and certification that meets OSHA-ANSI requirements. OSHA is the Occupational Safety and Health Administration; ANSI is the American National Standards Institute.

The courses, customized to meet the specific needs of customers, can be taken either at the customer’s site or at AP’s training centers around the country. They include aerial lift operator training, forklift operator certification, crane rigging instructor courses, mobile crane operator certification, crane operator training, overhead crane training, and rigging and signal-person qualification training.

For more information, visit the company’s website at www.ProbilityMedia.com

Let us hear your thoughts: ProBility Media Corp. Message Board

• Alzheimer’s is America’s most expensive disease, with a new diagnosis every 66 seconds
• IGC’s unique use of marijuana extracts in combination therapy for potential Alzheimer’s breakthrough shows promise
• Low market cap could make IGC a big winner for early investors

Alzheimer’s disease is one of the greatest medical, ethical, and financial challenges facing society today. Currently, more than 5.3 million Americans and their families have to deal with Alzheimer’s disease, and projections suggest that number will nearly triple to 14 million Americans by 2050. Globally, the figures are even more staggering, with about 47 million people worldwide currently diagnosed and projections at 132 million in less than three decades. Right now, someone in America develops Alzheimer’s every 66 seconds, and soon, this deadly diagnosis is expected to occur every 33 seconds.

Alzheimer’s is already the country’s most expensive disease. In 2016 U.S. costs totaled $236 billion and global costs exceeded $600 billion. These figures will skyrocket unless scientists develop new approaches to prevent or cure this insidious disease. Given the magnitude of the problem, pharmaceutical companies are scrambling to find ways to mitigate the disease’s devastation.

With so much on the line, it’s no wonder that Wall Street has already started to place bets on who might be a winner in this race. In this vein, Goldman Sachs recently highlighted Biogen (NASDAQ: BIIB) and its lead pipeline Alzheimer’s drug as one of the first to possibly prevent or slow the progression of the disease (http://dtn.fm/QoqT5). Goldman pegged potential drug sales at over $12 billion and targeted the $60 billion market cap stock at a 17 percent premium, if successful. However, everyone knows there are no guaranteed winners in this race. A broad spectrum of options must be considered if investors want to participate in the enormous upside potential of an effective Alzheimer’s treatment.

One compelling candidate with a promising patent pending Alzheimer’s treatment protocol and ridiculously low market valuation is India Globalization Capital (NYSE MKT: IGC). IGC is a pioneer in the development of new classes of phytocannabinoid pharmaceuticals with broad therapeutic applications for both humans and animals. IGC’s pipeline of patented and patent pending therapeutics include treatments for pain, post-traumatic stress disorder, cachexia, neurologic disorders, Parkinson’s, and, now, Alzheimer’s disease.

IGC recently acquired the exclusive rights to its novel THC-based treatment for Alzheimer’s disease from the University of South Florida (http://www.igcinc.us/alzheimers-disease/). The patent identifies discovery of a new pathway in which low doses of THC bind to amyloid beta plaques and prevent those plaques from aggregating on neurons, which is exactly what occurs in Alzheimer’s disease and causes cognitive decline.

IGC plans to enter clinical trials this year on its potential cannabis-based blockbuster treatment for Alzheimer’s, as well as on the company’s primary pipeline of other major therapeutics that address large market maladies. Any one of these trials could provide breakthrough treatments for previously untreatable disease. With a market capitalization currently around $10 million, IGC is one very interesting bet investors may want to place in this race for an effective Alzheimer’s treatment. Any positive results from the clinical trials could easily catapult valuation and make IGC a big winner for early investors.

For more information, please visit www.IGCInc.us

• Legal marijuana sales projected to exceed $20 billion within four years
• Federal banking restrictions make cannabis a cash business
• SING developing bitcoin-based payment solutions

Growing as much as 30 percent annually, legal marijuana sales in North America topped $6.7 billion last year and are projected to exceed $20.2 billion within four years (http://dtn.fm/Mhz0k). That’s eye-popping growth by almost any measure. However, this new found avalanche of revenues is shunned by banks.

Most banks won’t touch cannabis cash, because marijuana is illegal under U.S. federal law and banks must comply with federal regulations to maintain good standing. Banks just don’t want to be in the middle of a federal government versus state’s rights issue and risk losing their charter to operate. Effectively, this makes legal cannabis a cash-only business.

An inconvenience for consumers, it’s an enormous problem for private marijuana growers and distributors, creating transactional obstructions within booming businesses. Transacting $20+ billion of business annually in cash is no easy task. Real complications come on the operational end of businesses. There are multiple obvious security risks to business owners and employees paid in cash. Then the headaches really expand when realizing that all operational expenses, like utility bills, are cash payments. Complications and penalties further ensue when paying federal employee-withholding taxes and business income taxes, where headaches turn into migraines.

This constriction in the marijuana money spigot may be solved by a bitcoin payment solution for the marijuana industry, providing a much-needed financial transaction option and allowing cannabis businesses to accept credit card payments without the cooperation of banks or the FDIC. SinglePoint, Inc. (OTC: SING) has announced just such an initiative to develop a bitcoin payment solution for the cannabis industry. SING has partnered with First Bitcoin Capital Corp., an industry-leading bitcoin and blockchain technology provider (http://dtn.fm/Wu4Z3), to develop and distribute a viable payments solution targeted at “high-risk payment verticals including the cannabis industry” to “fill the payments gap that currently exists.”

Bitcoin, the world’s first and most recognized cryptocurrency, recently vaulted to new record highs above $4,000. Valued around seven dollars five years ago, the digital currency has quadrupled in value in 2017, jumping 40 percent in August alone (http://dtn.fm/7kUeV). Cryptocurrencies have attracted a lot of attention in recent years. The underlying blockchain technology of bitcoin and other cryptocurrencies has the potential to transform transactional business by transferring value anywhere around the world without the need of traditional intermediaries such as clearing firms or banks. The ability to transfer value solely through software could become a transformational breakthrough.

As part of a broad strategy to cement its position in the cannabis industry, SinglePoint has been actively providing corporate solutions to cannabis businesses through its SingleSeed subsidiary. Without actually touching the plant, SinglePoint profits from the booming marijuana markets by providing much-needed business solutions to growers and providers. Providing a payments solution to the projected $20+ billion marijuana markets would be a game changer. SING’s strategic joint venture partnership with First Bitcoin Capital Corp. may very well be the transformational breakthrough needed by the burgeoning marijuana industry.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board

• Survey respondents use CBD to treat anxiety, depression, insomnia and joint pain
• ADYNF is researching impact of cannabidiol products in treatment of mental health issues and cancers
• 61% of consumers surveyed said they are spending greater than $50 monthly on CBD products

Algae Dynamics Corp. (OTCQB: ADYNF) could be among the chief beneficiaries of a recent survey that found that 42% of respondents chose cannabidiol (CBD), derived from hemp or marijuana, and dropped traditional medicines (http://dtn.fm/O1sJM). In addition, an “Understanding Cannabidiol” survey of some 2,400 members of HelloMD, an online CBD community, and market research firm Brightfield Group jointly found that, by an overwhelming majority, respondents favored CBD made from cannabis rather than industrial hemp (http://dtn.fm/XbGU6).

CBD is being used instead of traditional medicines to treat anxiety (67%), insomnia (60%), joint pain and inflammation (52%) and depression (43%). A total of 61% of survey-takers said that they spend more than $50 monthly on CBD products, while more than half of respondents said they use oil cartridges and vaping. Notably, more than half (58%) of those surveyed are women.

The study found that 42% of respondents use cannabis rather than traditional medications for depression, anxiety, joint pain and anxiety, and some 80% said they find CBD products to be very or extremely effective treatments. Some 90% said they would be likely to buy marijuana-based CBD-only products.

Also, 53% of CBD users purchase CBD products from storefront dispensaries, 31% through local delivery services, and 17% online. Not only do 29% of this group find that CBD products provide the best medical relief, but, in the study’s words “about 66% of CBD users indicated that CBD products are either more effective or much more effective in relieving their medical conditions than are over-the counter (OTC) products.”

Algae Dynamics, headquartered and doing business in Ontario, Canada, is a development stage company which is publicly traded in the U.S. It maintains university collaborations to develop specific cannabis oil product lines, with the University of Waterloo and the University of Western Ontario. It specializes in cannabis oil extraction and hemp oils.

ADYNF is working with the University of Western Ontario to explore the impact of cannabis oil, its constituents and other botanical extracts that lead to development of unique products for the treatment of mental health issues, such as post-traumatic stress disorder, anxiety, depression, and schizophrenia.

With the University of Waterloo, ADYNF is performing fundamental research on cannabis oil leading to the treatment of cancers of the pancreas, breast, prostate and colorectum. ADYNF is seeking to combine the benefits of algae and cannabis oils and their role in the cancer-related potential treatment by botanical oils, specifically focusing on cannabis.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

• Formally announces subscription service Chinesefn.com, offering real-time reporting on digital currency news
• Published report analyzes jump in bitcoin valuation and its larger role in legalized marijuana markets
• CIIX targets China, which has an estimated 85% share of the bitcoin market

ChineseInvestors.com, Inc. (OTCQB: CIIX), along with other companies in the cannabidiol (CBD) and legalized cannabis industries, are increasingly relying on bitcoin cryptocurrency for transactions. Not only has the value of bitcoin skyrocketed to greater than $4,000 in the past year, it solves the problem of transactions in this largely unbankable market.

In a July press release, the company formally announced the debut of its new cryptocurrency education and trading subscription service on Chinesefn.com, the company’s own financial website for the Chinese-speaking community. The new service will offer coverage of the emerging digital currency world. Through its new subscription service, CIIX endeavors to become the leading digital currency education site for the global Chinese-speaking market.

CIIX’s goal is to become a leading Chinese publicly-traded company offering real-time information on its website, conducting research and development of legalized cannabidiol and providing global distribution of hemp-based cannabidiol and other health products. The firm has an online store in the free trade zone of Shanghai, China, and plans to open a brick-and-mortar unit in San Gabriel, California.

Bitcoin jumped 500% from $200 to $1,000 in January 2017, and it recently reached a record-high of more than $4,500. Warren Wang, founder and CEO of CIIX, has noted his belief that it can climb even higher. “With an estimated 85% market share, China is one of the dominant players controlling bitcoin volume, along with Japan (which recently legalized bitcoin as a form of payment) and the United States,” he noted in a recent news release. “CIIX intends to provide fundamental knowledge to Chinese speaking newcomers to cryptocurrency, including straightforward explanations of the basics of cryptocurrency, how to buy it and straightforward trading guidelines.”

Fueling part of the growth, according to a newly-published report (http://dtn.fm/z10CT), is the widespread use of bitcoin in the CBD and legalized marijuana industries. In this non-traditional, unbankable marketplace, suppliers, wholesalers and retail dispensaries are using bitcoin for transactions. While most dispensaries are currently cash-only businesses, bitcoin could enable consumers to complete purchases free of traditional banks.

The recent surge in interest related to cryptocurrency and its underlying blockchain technology has been impossible to ignore. Without a doubt, bitcoin on its own presents a valuable investment opportunity, and its role in the future of CIIX and other industry players is growing in importance.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• SinglePoint recently completed acquisitions of Convectium and DIGS Hydro
• The company offers an online payment solution through a partnership with First Bitcoin Capital
• Online payments and marketing services are available through SingleSeed.com

SinglePoint, Inc. (OTC: SING) revealed in a July 18, 2017, audio press release that it is now working with a cryptocurrency expert to lead an initiative to develop a payment solution designed for high risk customers. The company has grown from a full service mobile tech provider to a publicly traded holding company serving the cannabis market. Thanks to a joint venture with First Bitcoin Capital Corp., according to the audio press release (http://dtn.fm/K68cB), efforts to deliver a testable solution within 60 days are underway.

Helping to drive a consumer-first approach, the joint venture is expected to yield an easier transaction at the point of sale. In addition, two recent acquisitions are driving SinglePoint’s acquisition and growth strategy. One is DIGS Hydro, which now has two operating stores in Southern California and plans to open a third. The company, specializing in growing, cultivating and consulting in the cannabis industry, has seen growth in its first two quarters. The acquisition of Convectium, which manufactures and supplies the 710Shark oil filling machine, has been fulfilling as well.

In a recent podcast (http://dtn.fm/Mw9aP), Greg Lambrecht, CEO of SinglePoint, interviewed Wil Ralston, VP of sales and marketing. The two discussed how a new payment solution will avoid issues of purchasing cannabis products through banks, as well as the company’s presence in the OTC markets. Ralston also discussed the expansion of Convectium into a new office, with the addition of five new sales people and an operations specialist, and how it is driving the company’s acquisition phase and revenues.

SinglePoint is also developing an online marketing strategy, which involves selling products nationwide through the DIGS website – DIGSHydro.com. The recently acquired subsidiary received a significant purchase order in June to offer supplies and services to a major biomedical company. Payment solutions are already being offered through the online portal and subsidiary at SingleSeed.com, available now to cannabis retailers. It offers credit card processing, pay by text, cashless ATM, and point of banking services.

The company is also looking into additional acquisition options. It is planning to acquire a technology-driven delivery company and another that provides solar solutions to commercial cannabis growers. It has a presence in the solar industry in parts of Arizona, Texas, and southeast New York. In addition to payment processing, mobile messaging services are available, so companies can reach out to mobile subscribers with deals, coupons, and other notifications via SMS.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board

The Securities and Exchange Commission has issued a temporary trading suspension of First Bitcoin Capital Corp. (OTC: BITCF) shares because of concerns about the accuracy and adequacy of public information on the Canadian company.

The order took effect at 9:30 a.m. EDT last Thursday and terminates at 11:59 a.m. on September 7, 2017. The SEC cited concerns about the company, including the value of BITCF’s assets and its capital structure, in a news release accompanying the suspension order.

Shares of First Bitcoin Capital are traded over-the-counter and were last trading at $1.79 per share, according to Bloomberg. Shares had risen almost 7,000 percent this year prior to the suspension order. By contrast, the S&P 500 is up nine percent during the same time period.

“The Commission cautions broker-dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the company,” the SEC noted in its statement.

First Bitcoin Capital management issued a notice to shareholders downplaying the 10-day suspension.

“The company has retained competent SEC counsel to work with the SEC to learn of any concerns beyond the over exuberant market for our shares such as our disclosures of assets and capital structure,” the company stated in its shareholder letter. “We believe that there is likely a misunderstanding or a simple clarification necessary and that it would have been better for the SEC to ask us for this information before taking such drastic action.”

According to its website, First Bitcoin Capital is a publicly-traded Canadian company engaged in various digital cryptocurrency-related business lines. It holds proprietary blockchain technologies and operates a digital currency exchange.

For more information, visit the company’s website at www.BitcoinCapitalCorp.com

• 19 patent applications filed in the United States and internationally (under the Patent Cooperation Treaty), with national filings in 44 countries
• Collaborative research and development agreement with Canada’s National Research Council to investigate opportunities associated with bioavailability enhancement of certain compounds, including those in cannabinoids, vitamins, NSAIDs and nicotine
• Out-licenses its patented technology to third party partners, with several deals signed or pending

When Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) researchers tackled the issue facing consumers of edible cannabinoids – poor absorption of the product’s bioactive compounds by the body’s gastrointestinal tract – an important statement led the way: bioavailability matters. The company realized that if hemp oil ingredients were infused within lipids found in popular foods, the common problems of bad taste, poor absorption in the body and lack of product variety could be solved.

Lexaria has since developed a superior method of lipid-delivery technology through a patented process that does this by infusing the beneficial elements of hemp oil to lipid molecules. Lexaria reminds consumers that it is not mixing hemp oil into a product; it is infusing organically sourced, high purity hemp oil inside the molecules of other ingredients to produce superior tasting and performing food and beverages, including premium teas, protein energy bars and hemp oil capsules formulated with ginseng and ginkgo for enhanced memory and focus.

Additionally, this technologically superior method of delivery is being considered for other products in demand by consumers, namely nicotine-based products. Lexaria’s method could remove many of the dangerous side effects of nicotine, although the patented molecular delivery technology for this product remains in its early stages (http://dtn.fm/c2VCP).

Lexaria is also seeking patents to use its lipophilic enhancement technology for tetrahydrocannabinol (THC) and other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs such as ibuprofen), nicotine and other molecules. New business-to-business relationships are on the horizon in the fields of vitamins, NSAIDs and nicotine delivery.

For more information, visit the company’s website www.LexariaEnergy.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board

• An early mover in the Canadian cannabis space
• Serving Canada’s most populous province
• New funding deal signed for $15 million at $2.25 per share

As befits its status as a first mover in the Canadian cannabis space, ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) is racing ahead with plans to supply the medical marijuana needs of Canada’s most populous province. Construction plans at its Kimmett facility in the third quarter of 2017 remain on schedule, and the previously announced plans for a 71,000 square foot phase 1 project have been expanded to 100,000 square feet. The company recently signed a funding deal that prices the business well above market valuation. It appears that ABcann is one MMJ outfit that the smart money is betting on.

ABcann was one of the earliest players to apply for a cannabis grower’s license in Canada, which was granted in March 2014, well before the current Access to Cannabis for Medical Purposes Regulations (ACMPR) were implemented on August 24, 2016. That early start has advanced ABcann much further along the learning curve than subsequent licensees. In addition, having worked in collaboration with the University of Guelph in Ontario, Canada, to study the growing process, ABcann’s expertise is superior to most other LPs. It has developed state-of-the-art growing technology that produces high yields and consistency in its produce as it scales up. Also, somewhat like in retail, where location is a major determinant of success, ABcann’s location is fortuitous. Its operations are situated in Canada’s most populous province of Ontario, which, with 13.5 million people, accounts for close to 40 percent of Canada’s total population.

Knowledge of the growing process is particularly important if a licensed producer is going to scale up successfully. An essential requirement of medical marijuana is consistency. The product must be relied on to deliver a standardized quantity and quality of active ingredients every time it’s taken. Imagine the peril to patients of undergoing prescribed regimens of a medication with psychoactive properties where the dosages vary randomly.

Quality is obviously a crucial issue and, indeed, was one of the reasons that ABcann was founded by Ken Clement. ABcann’s mission, he has said, is “to deliver consistent, standardized medicinal cannabis that the public and patients can consistently rely on” (http://dtn.fm/wGg26). Now, ABcann is able to produce an organically grown, pesticide-free, standardized product with a growing system that controls air quality, carbon dioxide and oxygen levels, water quality and volume, light spectrum and cycles, temperature and humidity, plant nutrition and the curing process.

Earlier this month, ABcann announced completion of the initial funding phase of its partnership with Cannabis Wheaton (TSX.V: CBW). Under the deal, CBW has purchased $15 million worth of ABcann common shares at $2.25 per share. The cash forms part of a larger phased investment by Cannabis Wheaton that is expected to fund an additional 50,000 square feet of production space, capable of producing 35,000 kilograms of product per year, at ABcann’s second facility. This expansion comes alongside ABcann’s existing construction plans for a 100,000 square foot facility at its Kimmett property in Napanee, Ontario.

Since debuting on the Toronto Venture Stock Exchange at $1.00, ABcann stock has traded down a little, but, as recent events indicate, it may be a diamond in the rough. The Cannabis Wheaton deal valued the stock, which currently trades at C$0.87, at $2.25.

For more information, visit the company’s website at www.ABcann.ca

Let us hear your thoughts: ABcann Global Corp. Message Board